Imatinib Cipla

Medicinal product

(Invented) name

Imatinib Cipla

Active substance (s)

Imatinibas

Strength

400 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EA01, imatinib

Marketing authorisation holder

UAB Viasana, Lietuva

Date of authorisation

2020-05-20

Date of renewal

Documents

1297_Imatinib Cipla_400mg_kiet_kaps_PZPL_2020-05-20.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

kapsulėje yra	1 vnt.
Imatinibas	400 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
104120	90223	1090223	lizdinė plokštelė	N30		Receptinis	LT/L/20/1297/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
	Išregistruotas
2020-05-20	Registruotas